Glycated haemoglobin versus fasting plasma glucose for type 2 diabetes point of care screening: a decision model cost-effectiveness analysis

Glycated haemoglobin versus fasting plasma glucose for type 2 diabetes point of care screening: a decision model cost-effectiveness analysis

Abstract Introduction Whereas fasting plasma glucose (FPG) is cheaper, the glycated haemoglobin (HBA1c) test, which does not require fasting, is more convenient for diabetes screening and could be available to patients throughout the day. In this study, we compared the cost effectiveness of the HBA1...

Full description

Saved in:
Bibliographic Details
Main Authors: Francis Xavier Kasujja, Meena Daivadanam, Roy William Mayega, Fred Nuwaha, Ronald Kusolo, Elizabeth Ekirapa
Format: Article
Language:English
Published: BMC 2025-05-01
Series:BMC Health Services Research
Subjects:
Cost-effectiveness analysis
Diabetes tests
HBA1c
FPG
Diabetes detection
Online Access:https://doi.org/10.1186/s12913-025-12840-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12913-025-12840-4

Similar Items